Chimeric Therapeutics Ltd appoints experts to Cellular Immunotherapy Scientific Advisory Board
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.
Press Release : Novartis provides update on BELINDA study investigating Kymriah(R) as second-line treatment in aggressive B-cell non-Hodgkin lymphoma
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Setback for Novartis s Kymriah: CAR-T therapy fails to meet primary endpoint in Phase 3 study
biopharma-reporter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharma-reporter.com Daily Mail and Mail on Sunday newspapers.
Novartis falls behind rivals in race to bring CAR-T to early lymphoma
biopharmadive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharmadive.com Daily Mail and Mail on Sunday newspapers.